NHS National Pharmaceuticals Transition 2022_2
This is a contract result notice, not an open opportunity. Details from the official award data.
Invitation to offer for NHS National Pharmaceuticals Transition 2022_2<br/>Offer reference number: CM/PHG/22/5655<br/>Period of framework agreement: Dates detailed below, with an option or options to extend (at the discretion of the Authority) up to maximum contract length of 48 months.<br/>Potential periods of call-offs under the framework agreement:<br/>Transition: CESW: 01/12/2022 to 30/09/2023 (10 months)<br/>LSNE: 01/12/2022 to 31/05/2024 (18 months)<br/>NWLN: 01/12/2022 to 31/05/2023 (6 months)
What this notice demands of you
1 named, none in explicit obligation language. Each one is quoted from the notice.
Invitation to offer for NHS National Pharmaceuticals Transition 2022_2<br/>Offer reference number: CM/PHG/22/5655<br/>Period of framework agreement: Dates detailed below, with an option or options to extend (at the discretion of the Authority) up to maximum contract length of 48 months.<br/>Potential periods of call-of…
Matched against the notice text, so this is a floor — the tender pack will demand things the notice never mentions. “Says must” means the quoted sentence itself used obligation language; anything ambiguous is left as a mention.
Make the case to bid
Reveal who to approach at NHS England, and generate a go-to-market strategy from their news, accounts and people.
Free to start. Named contacts come from published notices; the strategy is generated from the buyer’s news, accounts and people.
- OCID
- ocds-h6vhtk-03538e
- Stage
- award · Awarded
- Source
- Find a Tender
- Buyer ref
- 031197-2022
Contains public sector information licensed under the Open Government Licence v3.0. Source data © Crown copyright.
Who wins this kind of work
The suppliers and buyers around this opportunity — drawn from official award data. Drag to orbit; click a node to explore.
Top suppliers & buyers in Medical Equipment & Pharmaceuticals
NHS England’s tender network